Form D · Biotechnology

RheoTek Medical LLC

New York, NY · CIK 0001989178

Offering snapshot reported Sep 6, 2024 · SEC filing

Reported sold
$1.09M
Offering amount: $4M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 31, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$543K$1.09MSep 12, 2023: $1,060,000.00Sep 12, 2023Sep 6, 2024: $1,085,000.00Sep 6, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,060,000 → $1,085,000
  • Reported investors14 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 6, 2024Amendment$1,085,000$25,000vs Sep 12, 202315SEC filing
Sep 12, 2023Initial$1,060,000No comparison14SEC filing

Offering details

Securities
Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-491866
Simple agreement for future equity

Source: Form D, filed Sep 6, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Scott Bartlett Director, Executive
Steven Duddy Director, Executive
Daniel Mazzaferro Director, Executive
Steven A. Schultz Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
376 Bleecker St, Unit 2
New York, NY, 10014